Axoltis Pharma
- Address
- Pepiniere Laennec, 60 Avenue Rockefeller
Sponsor Overview
Specializations
Amyotrophic Lateral Sclerosis
Axoltis Pharma’s clinical research is centred on Amyotrophic Lateral Sclerosis, with an emphasis on neurological disease progression and markers linked to motor neuron degeneration. The sponsor’s trial activity in ALS reflects a focused interest in the clinical and biological features of this neurodegenerative disorder.
- Motor neuron disease
- Neurodegeneration
- Neuromuscular impairment
The research landscape includes work related to disease monitoring in ALS, with attention to neurological biomarkers and the underlying pathology of progressive functional decline.
Neurobiomarkers
The sponsor’s trial activity involves interest in blood-based indicators of neuronal injury, particularly neurofilament light chain as a marker associated with axonal damage and disease activity in ALS.
- Blood neurofilament light chain
- Biomarker surveillance
- Neuronal injury markers
This area reflects a therapeutic focus on measurable indicators that can inform the clinical understanding of neurodegenerative disease.
Blood-Brain Barrier Integrity
Axoltis Pharma also shows interest in blood-brain barrier function, with research attention directed toward biomarkers of BBB integrity in the setting of ALS. This places vascular and barrier-related neurological mechanisms within its clinical research scope.
- Blood-brain barrier
- BBB integrity
- Cerebrospinal fluid biomarkers
The sponsor’s work includes evaluation of biomarkers found in both blood and cerebrospinal fluid, supporting interest in central nervous system barrier disruption.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| Phase II Randomized, Double-Blind, Placebo-Controlled Study of NX210c in Adult Patients with Amyotrophic Lateral Sclerosis (ALS) |  France | Not Recruiting |
Data & Insights
This sponsor works with 2 molecules, of which 1 is not being studied by other sponsors.
This sponsor has worked with 16 sites across their trial portfolio.
Therapeutic Focus
- 1.Musculoskeletal Diseases1 trial238 other sponsors
- 2.Nervous System Diseases1 trial449 other sponsors
Partnered Research Centres
16 centres- Address
- 264 Boulevard de Saint Pierre, 13005 Marseille
- Address
- 2 Avenue Martin Luther King, 87000 Limoges
- Address
- 165 Chemin Du Grand Revoyet, 69310 Pierre Benite
- Address
- 4 Rue Larrey, 49100 Angers
- Address
- Boulevard Tanguy Prigent, 29200 Brest
- Address
- 2 Boulevard Tonnelle, 37044 Tours
Want to get in touch with this sponsor?
Send a question and we'll pass it on to Axoltis Pharma.
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.